ESR1 and breast cancer: As shown in Figure 1A (right panel), all TNBC cell lines and the ER/PR double-negative, HER2-positive SKBR3 cells (group I) exhibited higher ECAR and lower OCR compared with the receptor-positive breast cancer cells (group II).